» Authors » Sara Custodio-Cabello

Sara Custodio-Cabello

Explore the profile of Sara Custodio-Cabello including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 113
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Custodio-Cabello S, Pacheco-Barcia V, Palka-Kotlowska M, Fernandez-Hernandez L, Del Alamo J, Oliveros-Acebes E, et al.
Urol Oncol . 2024 Jun; 42(10):331.e13-331.e24. PMID: 38926076
Background: About 8% to 12% of patients presenting with mHSPC exhibit germline pathogenic variants (PV) in cancer predisposition genes. The aim of this study is to assess the presence of...
2.
Cabezon-Gutierrez L, Pacheco-Barcia V, Carrasco-Valero F, Palka-Kotlowska M, Custodio-Cabello S, Khosravi-Shahi P
Mediastinum . 2024 Jun; 8:33. PMID: 38881809
Background And Objective: Thymoma, thymic carcinoma and thymic neuroendocrine tumors originate from the epithelial cells of the thymus and account for the thymic epithelial tumors (TETs). Although TETs are uncommon,...
3.
Pacheco-Barcia V, Custodio-Cabello S, Carrasco-Valero F, Palka-Kotlowska M, Marino-Mendez A, Carmona-Bayonas A, et al.
World J Gastrointest Oncol . 2024 Mar; 16(2):386-397. PMID: 38425396
Background: The prognostic value of the Systemic Inflammation Response Index (SIRI) in advanced pancreatic cancer is recognized, but its correlation with patients´ nutritional status and outcomes remains unexplored. Aim: To...
4.
Lara-Morga C, Palka-Kotlowska M, Custodio-Cabello S, Pacheco-Barcia V, Cabezon-Gutierrez L
Explor Target Antitumor Ther . 2023 May; 4(2):307-315. PMID: 37205314
A clinical case of a 61-year-old female diagnosed with stage IV right colon adenocarcinoma (unresectable liver and multiple lymph node metastases at the time of diagnosis), Kirsten rat sarcoma viral...
5.
Cabezon-Gutierrez L, Custodio-Cabello S, Palka-Kotlowska M, Diaz-Perez D, Mateos-Dominguez M, Galindo-Jara P
Eur J Surg Oncol . 2022 Nov; 49(2):323-328. PMID: 36400657
Introduction: This is a review of the evidence from studies of the efficacy and tolerability of neoadjuvant immunotherapy for mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) Locally Advanced Rectal Cancer...
6.
Cabezon-Gutierrez L, Custodio-Cabello S, Palka-Kotlowska M, Alonso-Viteri S, Khosravi-Shahi P
Clin Lung Cancer . 2021 Apr; 22(5):381-389. PMID: 33875382
Immunotherapy has markedly improved the survival rate of patients with non-small cell lung cancer (NSCLC) and has introduced a new era in lung cancer treatment. Although some patients achieve durable...
7.
Cabezon-Gutierrez L, Palka-Kotlowska M, Custodio-Cabello S
Rev Esp Geriatr Gerontol . 2021 Mar; 56(6):369-370. PMID: 33773836
No abstract available.
8.
Custodio-Cabello S, Cabezon-Gutierrez L, Palka-Kotlowska M, Oliveros Acebes E, Khosravi-Shahi P
Cureus . 2021 Mar; 13(1):e12916. PMID: 33654599
Merkel cell carcinoma (MCC) is a rare neuroendocrine cutaneous malignancy. During early stages, surgery is the primary treatment followed by radiotherapy in patients at high risk of recurrence. Definitive radiation...
9.
Palka-Kotlowska M, Custodio-Cabello S, Oliveros-Acebes E, Khosravi-Shahi P, Cabezon-Gutierrez L
Int J Infect Dis . 2021 Feb; 105:15-20. PMID: 33556611
Background: Patients with a history of active malignancy are at increased risk of infection and COVID-19-related complications. Sanitary protection measures are not specifically recommended within households. This study examined the...
10.
Cabezon-Gutierrez L, Custodio-Cabello S, Palka-Kotlowska M, Oliveros-Acebes E, Garcia-Navarro M, Khosravi-Shahi P
Cancer Treat Rev . 2020 Sep; 90:102102. PMID: 32947121
Background: Coronavirus disease in 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic. Published data suggests that patients with a history of...